HALF YEARLY RESULTS
Mankind Pharma Ltd.
BSE
Jun 06
2352.90
-8.35 ( -0.35%)
Volume
10596
Prev. Close
2361.25
Open Price
2376.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
2352.40
-6.80 ( -0.29%)
Volume
353199
Prev. Close
2359.20
Open Price
2370.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Halfyearly Results
for the last 5 years.
ISIN No
|
INE634S01028
|
Market Cap. ( ₹ in Cr. )
|
97076.74
|
P/BV
|
9.19
|
Book Value ( ₹ )
|
256.04
|
BSE Code
|
543904
|
52 Week High/Low ( ₹ )
|
3055/1901
|
FV/ML
|
1/1
|
P/E(X)
|
48.76
|
NSE Code
|
MANKINDEQ
|
Book Closure
|
|
EPS ( ₹ )
|
48.25
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Net Sales/Income from operations | 4523.16 | 4933.00 | 4511.25 | 4753.56 | 3808.35 |
Total Income From Operations | 4523.16 | 4933.00 | 4511.25 | 4753.56 | 3808.35 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 396.48 | 386.36 | 418.37 | 443.38 | 325.33 |
Purchase of Traded Goods | 829.85 | 988.27 | 977.48 | 1094.44 | 923.97 |
Increase/Decrease in Stocks | -9.45 | 15.23 | -43.19 | 17.83 | 49.74 |
Employees Cost | 1058.54 | 1047.96 | 1000.61 | 981.49 | 851.55 |
Depreciation | 192.27 | 168.82 | 172.02 | 145.58 | 138.32 |
Provisions And Contingencies | 15.82 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 1014.07 | 1170.95 | 1007.54 | 1041.76 | 903.11 |
Total Expenses | 3497.58 | 3777.59 | 3532.83 | 3724.48 | 3192.01 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 1025.58 | 1155.41 | 978.42 | 1029.08 | 616.34 |
Other Income | 289.14 | 200.59 | 151.08 | 115.55 | 74.86 |
P/L Before Interest, Excpt. Items & Tax | 1314.72 | 1356.00 | 1129.50 | 1144.63 | 691.20 |
Interest | 361.72 | 8.18 | 8.29 | 6.28 | 10.13 |
P/L Before Exceptional Items & Tax | 953.00 | 1347.82 | 1121.21 | 1138.36 | 681.07 |
P/L Before Tax | 953.00 | 1347.82 | 1121.21 | 1138.36 | 681.07 |
Tax | 154.16 | 261.13 | 179.97 | 256.19 | 151.21 |
P/L After Tax from Ordinary Activities | 798.84 | 1086.69 | 941.24 | 882.17 | 529.86 |
Extra Ordinary Item | 0.00 | 61.23 | 0.00 | 0.00 | 0.00 |
Net Profit/Loss For the Period | 798.84 | 1147.92 | 941.24 | 882.17 | 529.86 |
| | | | | |
Equity Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 |
Reserves And Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 7743.85 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 19.36 | 28.65 | 23.50 | 22.02 | 13.23 |
Diluted EPS (Rs.) | 19.36 | 28.60 | 23.50 | 21.99 | 13.23 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 19.36 | 28.65 | 23.50 | 22.02 | 13.23 |
Diluted EPS (Rs.) | 0.00 | 28.60 | 0.00 | 21.99 | 0.00 |
| | | | | |
PBITOE Margin (%) | 22.67 | 23.42 | 21.68 | 21.64 | 16.18 |
PBTE Margin (%) | 21.06 | 27.32 | 24.85 | 23.94 | 17.88 |
PBT Margin (%) | 21.06 | 27.32 | 24.85 | 23.94 | 17.88 |
PAT Margin (%) | 17.66 | 23.27 | 20.86 | 18.55 | 13.91 |